Clinical Management of Pancreatic Cancer
From Diagnosis to Palliative Care
- 1st Edition - May 1, 2027
- Latest edition
- Editors: Takuji Okusaka, Eileen M. O’Reilly
- Language: English
Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care provides comprehensive guidance and support at every step of the pancreatic cancer journey, coveri… Read more
Description
Description
Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care provides comprehensive guidance and support at every step of the pancreatic cancer journey, covering all aspects from initial diagnosis to compassionate and holistic care, ensuring healthcare professionals have the knowledge and resources they need for effective management and improved quality of life. The book not only presents the latest advancements in pancreatic cancer management, including innovative surgical techniques, targeted therapies, radiotherapy approaches, and palliative care interventions but also focuses on maintaining and improving patients' quality of life throughout their journey, incorporating palliative medicine and supportive care to alleviate symptoms and enhance overall well-being. IN 4 sections and 29 chapters Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care Advocates for patient-centered care by emphasizing communication, shared decision-making, and tailoring treatment approaches to individual needs and preferences. It raises awareness about pancreatic cancer, its challenges, and the importance of early detection, while also dispelling misconceptions and offering hope through informed management strategies. The book also highlights the significance of palliative medicine and comprehensive supportive care to manage symptoms, alleviate pain, and address psychosocial and emotional needs of both patients and their families.
Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care serves as a bridge between research and clinical practice, offering researchers a broader perspective and equipping clinicians with a valuable resource that enhances their knowledge, decision-making, and patient care skills in the realm of pancreatic cancer management.
Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care serves as a bridge between research and clinical practice, offering researchers a broader perspective and equipping clinicians with a valuable resource that enhances their knowledge, decision-making, and patient care skills in the realm of pancreatic cancer management.
Key features
Key features
- Provides the latest advancements, evidence-based approaches, and multidisciplinary insights to enhance knowledge and improve patient outcomes
- Delivers a structured and detailed overview of the clinical management of pancreatic cancer
- Presents insights on how to understand the complexities of diagnosis, treatment, and supportive care
- Facilitates collaboration among different specialists, enabling them to make informed decisions and provide well-coordinated care that addresses the various aspects of the disease
Readership
Readership
Clinicians and researchers working across the biosciences in fields of oncology
Table of contents
Table of contents
Section 1: Diagnosis
1. Risk factors for pancreatic cancer
2. Familiar risk factors and genetic testing for inherited mutation
3. Screening/surveillance in high-risk population to detect pancreatic cancer
4. Transabdominal ultrasonography for screening and diagnosis of pancreatic cancer
5. CT for diagnosis and staging of pancreatic cancer
6. MRI/MRCP for diagnosis and staging of pancreatic cancer
7. Endoscopic ultrasonography for imaging and pathological diagnosis for pancreatic cancer
8. Endoscopic retrograde cholangiopancreatography for imaging and pathological diagnosis for pancreatic cancer
9. PET/CT for diagnosis, staging and follow-up
10. Staging laparoscopy and laparoscopic ultrasound
11. Germline and tumor/somatic genomic testing
12. Staging for pancreatic cancer
Section 2: Treatments for resectable and borderline resectable pancreatic cancer
13. Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
14. Surgical resection for pancreatic cancer
15. Minimally invasive pancreatic surgery for pancreatic cancer
16. Postoperative adjuvant therapy for resectable and borderline resectable pancreatic cancer
17. Follow-up surveillance and management for patients after pancreatic surgery
Section 3: Treatments for locally advanced and metastatic pancreatic cancer
18. Treatment strategies for locally advanced pancreatic cancer
19. Chemoradiotherapy for locally advanced pancreatic cancer Gemcitabine-based chemoradiotherapy
20. First-line chemotherapy for locally advanced and metastatic pancreatic cancer
21. Second-line chemotherapy for advanced pancreatic cancer
22. Surgical resection following significant response to nonsurgical treatment for advanced pancreatic cancer
Section 4: Supportive and Palliative medicine for pancreatic cancer
23. Stents for obstructive jaundice and gastric outlet obstruction
24. Palliative surgery in advanced pancreatic cancer
25. Pain control
26. Managements for anxiety and depression
27. Advance care planning for pancreatic cancer patients
28. Venous thromboembolism in patients with pancreatic cancer
29. Managements for ascites
1. Risk factors for pancreatic cancer
2. Familiar risk factors and genetic testing for inherited mutation
3. Screening/surveillance in high-risk population to detect pancreatic cancer
4. Transabdominal ultrasonography for screening and diagnosis of pancreatic cancer
5. CT for diagnosis and staging of pancreatic cancer
6. MRI/MRCP for diagnosis and staging of pancreatic cancer
7. Endoscopic ultrasonography for imaging and pathological diagnosis for pancreatic cancer
8. Endoscopic retrograde cholangiopancreatography for imaging and pathological diagnosis for pancreatic cancer
9. PET/CT for diagnosis, staging and follow-up
10. Staging laparoscopy and laparoscopic ultrasound
11. Germline and tumor/somatic genomic testing
12. Staging for pancreatic cancer
Section 2: Treatments for resectable and borderline resectable pancreatic cancer
13. Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
14. Surgical resection for pancreatic cancer
15. Minimally invasive pancreatic surgery for pancreatic cancer
16. Postoperative adjuvant therapy for resectable and borderline resectable pancreatic cancer
17. Follow-up surveillance and management for patients after pancreatic surgery
Section 3: Treatments for locally advanced and metastatic pancreatic cancer
18. Treatment strategies for locally advanced pancreatic cancer
19. Chemoradiotherapy for locally advanced pancreatic cancer Gemcitabine-based chemoradiotherapy
20. First-line chemotherapy for locally advanced and metastatic pancreatic cancer
21. Second-line chemotherapy for advanced pancreatic cancer
22. Surgical resection following significant response to nonsurgical treatment for advanced pancreatic cancer
Section 4: Supportive and Palliative medicine for pancreatic cancer
23. Stents for obstructive jaundice and gastric outlet obstruction
24. Palliative surgery in advanced pancreatic cancer
25. Pain control
26. Managements for anxiety and depression
27. Advance care planning for pancreatic cancer patients
28. Venous thromboembolism in patients with pancreatic cancer
29. Managements for ascites
Product details
Product details
- Edition: 1
- Latest edition
- Published: May 1, 2027
- Language: English
About the editors
About the editors
TO
Takuji Okusaka
Takuji Okusaka serves as the Chief of the Department of Hepatobiliary and Pancreatic Oncology at the National Cancer Center Hospital, Japan. As a medical oncologist specializing in pancreatic, biliary tract, and liver cancers, he has devoted his career to improving the treatment of these highly challenging malignancies. He has led and contributed to numerous investigator-initiated and international clinical trials, particularly through the Japan Clinical Oncology Group, generating evidence that has helped establish contemporary standards of systemic therapy for pancreatic and biliary tract cancers. He has also played a central role in the development and revision of Japanese clinical practice guidelines for pancreatic and biliary tract cancers, thereby contributing to the dissemination of evidence-based care. He has published extensively in leading international journals and has been recognized as a Clarivate Highly Cited Researcher for the global influence of his scientific contributions.
Affiliations and expertise
National Cancer Center, JapanEO
Eileen M. O’Reilly
Eileen M. O'Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology at Memorial Sloan Kettering Cancer Center (MSK). She serves as the Section Head for Hepatopancreaticobiliary/ Neuroendocrine Cancers, Gastrointestinal Oncology Service, Co-Director Medical at the David M. Rubenstein Center for Pancreatic Cancer and is an Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College. Dr. O’Reilly is a clinical scientist whose research focuses on novel therapy development including targeted therapy, immunotherapy and biomarker development in pancreatic cancer.
Affiliations and expertise
Winthrop Rockefeller Endowed Chair in Medical Oncology, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA; Professor of Medicine, Weill Cornell Medical College, New York, USA